The current valuation score of Cytek Biosciences Inc is 8.56, ranking 57 out of 199 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -7.29, which is -9744.39% below the recent high of 703.39 and -115917.97% above the recent low of -8461.54.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.